Talk:Chris Gebhard
 | This article must adhere to the biographies of living persons (BLP) policy, even if it is not a biography, because it contains material about living persons. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libellous. If such material is repeatedly inserted, or if you have other concerns, please report the issue to this noticeboard.This page is about a politician who is running for office or has recently run for office, is in office and campaigning for re-election, or is involved in some current political conflict or controversy. For that reason, this article is at increased risk of biased editing, talk-page trolling, and simple vandalism.If you are a subject of this article, or acting on behalf of one, and you need help, please see this help page. |
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||
| ||||||||||||||||||||||||
relevance of cannabis content
editIt looks like a very slow edit war over the past year, with low-edit editors both adding and removing the following content:
In the 2020–2021 session, Gebhard opposed an amendment to House Bill 1024 that would have allowed medical patients to grow six cannais plants at home.[1][2] However, Gebhard did vote for House Bill 1024 without the home grow amendment, which allowed medical marijuana growers in Pennsylvania to remediate moldy product and use additional pesticides.[3] In 2023, Gebhard sponsored Senate Bill 773, a marijuana industry-backed bill "providing for limitations on permits and providing for additional dispensary permits authorized, for application and issuance of additional dispensary permits and for limitations on other additional permits or licenses."[4] Gebhard is a principle in Hoaster Gebhard & Co, an insurance company based in Lebanon, Pennsylvania.[5] Hoaster Gebhard & Co offers "marijuana insurance" for marijuana companies.[6]
References
I agree with the editors who've been removing this content. The main sources (legislative vote databases) are cherry-picked primary sources; there are no independent sources attesting any significance to Gebhard's votes on this issue. The hempgazette doesn't even mention Gebhard. The juxtaposition of Hoaster, Gebhard & Co (again, using only primary sources) appears to insinuate some sort of conflict of interest on Gebhard's part, but not citing any independent sources that make that connection. I don't see any reason why these two votes, out of all the votes Gebhard made, are WP:DUE for inclusion. Schazjmd (talk) 20:56, 10 June 2024 (UTC)